Abionic

Abionic SA is a company specializing in the development of ultra-rapid in vitro diagnostic tests, based in Lausanne, Switzerland.
Abionic has developed the, a point-of-care diagnostic platform using its patented nanofluidic technology. The is implemented in intensive care units and emergency departments to enable early identification of sepsis using a proprietary biomarker, Pancreatic Stone Protein.
The is also used in primary care for screening for the iron deficiency, respiratory allergies, and more recently for COVID-19 screening with an antigenic saliva and nasopharyngeal test.

WWW abionic.com

History

Abionic was founded in 2010 at the Swiss Federal Institute of Technology in Lausanne by Dr Nicolas Durand and Dr Iwan Märki.
In 2012, the company raised CHF 3.5 million in Series A funding. In 2014, Abiotic closed a CHF 8.2 million Series B funding round.
Abionic’s first allergy test was launched in May 2015.
The company received CE marks for the IVD CAPSULE PSP test for early sepsis diagnosis and the IVD CAPSULE Ferritin test in 2017. In the United States, Abiotic received FDA Approval for its first allergy panel test.
In 2018, the company closed a Series C fundraising round totaling CHF 20 million. The company launched a sepsis impact study in April 2019. It took place in 14 ICUs in 4 EU countries, for the use of the IVD CAPSULE PSP test on the abioSCOPE in the ICUs. Patient trials in the United States were launched in 2020 to validate the results of the European trial.
A CE mark for the abioSCOPE 2.0 was approved in 2019. Two years later, Abionic received a CE mark for the IVD CAPSULE COVID-19 Antigen test.
In 2024, the FDA issued 510 clearance for the pancreatic stone protein sepsis test.

Products

Abionic's solution is composed of the, an in vitro diagnostic device and the consumable called the IVD CAPSULE, which is a single-use and analyte-specific tests.
Test principle :
The test is based on mixing the patient's sample with a reagent containing fluorescent markers. The solution is then deposited on the capsule and enters nanochannels by capillary action. The volume-to-surface ratio then forces the molecules to interact immediately together, limiting their travel distance and reducing the incubation time to a few minutes. The concentration of the molecule of interest is then proportional to the intensity of the fluorescent signal measured by the.
;The different diagnostic tests developed by Abionic

The IVD CAPSULE PSP is a quantitative serological test providing results within five minutes for the early detection of sepsis. PSP concentration increases rapidly and up to 72 hours before the onset of clinical symptoms. Its availability at the patient's bedside provides an additional tool to assist healthcare professionals in the management of antibiotic treatment and helps to limit the development of bacterial resistance, which is a major public health issue.
The IVD CAPSULE Ferritin is a quantitative serological test providing results within 5 minutes from a 50 μL sample of capillary blood. It is intended to be used by healthcare professionals to identify iron deficiencies, affecting mainly pregnant women, people with chronic diseases, bleeding and inability to absorb iron.
The IVD CAPSULE COVID-19 is a qualitative test performed with a saliva or nasopharyngeal sample and which provides a result within 2 minutes. It identifies the presence of the SARS-CoV-2 to identify contagious individuals and reduce virus spread.
The IVD CAPSULE Aeroallergens is a semi-quantitative serological test at the point-of-care. It provides results within 12 minutes from a 50 μl sample of capillary blood. It is composed of 7 key allergens to help diagnose allergic asthma: Dog, cat, dust mites, Alternaria Alternata and timothy grass.

Other tests are under development: D-Dimer, CRP, PCT.

Recognition and awards

Year	Name of competition	Rank	Location
2010	PERL	1st	Lausanne
2010	DebioPharm Award for Life sciences	1st	Switzerland
2010	KPMG Inspiration	winner	Switzerland
2010	Venture Kick	winner of all 3 stages	Switzerland
2011	DeVigier	winner	Switzerland
2012	European Academic Enterprise Awards 2012	2nd	Europe
2012	Venture	6th	Switzerland
2012	Red Herring top 100 best European Startups	winner	Europe
2013	Swiss Excellence Product Award	winner	Switzerland
2013	Best Elevator Pitch Award	winner	Luxembourg
2016	Swiss Economic Forum	finalist	Switzerland
2017	Finance Monthly Game Changers Awards	winner	Switzerland
2018	EY Entrepreneur of the Year 2018	finalist	Switzerland
2018	Swiss Venture Club Award 2018	Finalist	Switzerland